INIncyte INCY · NASDAQ
$116.80 -0.06% (-$0.07)
- Market cap
- $23.7B
- Enterprise value
- $19.7B
- P/E
- 14.7x
- Forward P/E
- 37.2x
- PEG
- 0.0x
- P/S
- 4.1x
- P/FCF
- 12.3x
- EV/EBITDA
- 9.7x
- ROIC
- 22.9%
- Gross margin
- 92.6%
- Net margin
- 27.7%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -1.9x
- Beta
- 0.74
- Free float
- 99.1%
About the company
Incyte Corporation (INCY) is an American biopharmaceutical company specializing in the research, development, and commercialization of therapies focused on oncology and other serious diseases. The company is known for its strong emphasis on scientific research and innovation, leading to the discovery of new therapeutic possibilities. Incyte focuses on developing small molecule drugs and immunotherapies that have the potential to significantly improve patients' lives. Incyte Corporation (INCY) shares might be appealing to investors seeking involvement in the biotechnology sector with a focus on innovation and treatment of serious diseases.
Sector
Healthcare
Industry
Biotechnology
CEO
William J. Meury
Employees
2,844
Headquarters
Wilmington
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Earnings per share grew by 62% a year over the last 3 years.
- What to watch: Earnings per share swing sharply from year to year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 28 USD is left as net profit.
- What speaks for it: It earns 23 USD a year on every 100 USD of invested capital.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $3.85B against $31.8M.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number